StonvexLoading…
StonvexStonvexStonvexCore line items from BMEA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 | Q1 2022 2022-03-31 | Q3 2021 2021-09-30 |
|---|---|---|---|---|
Revenue | $1.24B | $1.07B | $1.07B | $1.07B |
Operating Income | $-23.48M | $-17.47M | $-16.40M | $-12.64M |
Net Income | $-22.89M | $-17.26M | $-16.37M | $-12.61M |
EPS (Diluted) | $-0.78 | $-0.59 | $-0.56 | $-0.43 |
Total Assets | $145.05M | $161.74M | $174.86M | $199.40M |
Total Liabilities | $14.41M | $11.35M | $10.10M | $8.07M |
Cash & Equivalents | $132.31M | $148.48M | $156.22M | $156.97M |
Free Cash Flow OCF − CapEx | $-42.53M | $-25.79M | $-10.09M | $-22.42M |
Shares Outstanding | 29.39M | 29.28M | 29.17M | 29.04M |